Next-generation sequencing (NGS) is a key tool for transcriptome analysis, with high sensitivity and a wide dynamic range. One challenge in NGS transcriptome analysis studies centers around FFPE (formaldehyde fixed paraffin embedded) tissue, in which the RNA is typically degraded.

Random-primed cDNA synthesis is an ideal solution for transcriptome analysis from FFPE tissue and other samples containing fragmented RNA; however, ribosomal RNA (which makes up ≥
90% of total RNA) must be removed from these samples prior to cDNA synthesis. The RiboGone - Mammalian kit uses hybridization technology and RNase H digestion to identify and specifically degrade/eliminate 5S, 5.8S, 18S, and 28S nuclear rRNA sequences and 12S mitochondrial RNA sequences from RNA derived from human, mouse, or rat tissues.

Total RNA extracted from curls of breast carcinoma FFPE tissue (Cureline), using the NucleoSpin totalRNA FFPE kit according to its protocol, is degraded. The profile of the RNA is illustrated on an electropherogram trace with a broad peak at <200 bp.

The RiboGone - Mammalian kit was used to clear rRNA from total RNA extracted from FFPE tissue. rRNA-depleted FFPE RNA was converted to cDNA with the SMARTer Universal Low Input RNA Kit for Sequencing according to the kit protocol. Illumina adapters and indices were added using the Low Input Library Prep Kit according to its protocol.

The library was sequenced on an Illumina MiSeq® instrument with ~6M 1 x 50 bp paired end reads. rRNA reads were reduced to 0.6% of total reads, and 16,463 genes were identified. RiboGone treatment and random-primed SMARTer cDNA synthesis preserve transcriptome data while eliminating rRNA.

Sequencing data generated from FFPE samples. rRNA reads were reduced to 0.6% of total reads. The number of reads that mapped to introns, exons, intergenic regions, rRNA, mitochondrial RNA, and unknown sources are shown as percentages of the total reads.

Random priming extends the applicability of transcriptome analysis to include samples which contain non-polyadenylated and/or compromised input RNA. However, in order to maximize RNA-seq data quality and quantity, random primed RNA-seq kits must be paired with rRNA removal methods. The RiboGone - Mammalian kit specifically removes 5S, 5.8S, 18S, and 28S rRNA sequences (as well as 12S mitochondrial rRNA sequences) from human, mouse, or rat total RNA. In this study, 16,463 genes were identified with an RPKM ≥0.1, while rRNA and mtRNA reads were reduced to <1% and ~2% of the RNA-seq library reads, respectively. These data indicate that SMARTer random-primed cDNA synthesis paired with RiboGone rRNA depletion yields high-value RNA-seq data, even from challenging samples such as small quantities of FFPE tissue.

Total RNA was extracted from curls of breast carcinoma FFPE tissue (Cureline) using the NucleoSpin totalRNA FFPE kit according to its protocol, using lysis method B with a 75-minute incubation at 56°C and the optional on-column DNase treatment. 30 ng of the extracted total RNA was cleared of rRNA using the RiboGone - Mammalian kit according to the RiboGone kit protocol. 8 µl of rRNA-depleted FFPE RNA was converted to cDNA with the SMARTer Universal Low Input RNA Kit for Sequencing according to the kit protocol, using 18 PCR cycles for ds cDNA amplification due to the small amount and degraded nature of the RNA extracted from the FFPE curls. Illumina adapters and indices were added using the Low Input Library Prep Kit according to its protocol.

The RNA-seq library was sequenced on an Illumina MiSeq Platform with 1 x 50 bp reads. The reads were trimmed by CLC Genomics Workbench and mapped to rRNA, the mitochondrial genome, and the human genome with RefSeq masking using CLC (% reads indicated). 16,463 genes were identified with an RPKM (reads per kilobase of exon per million of reads) of at least 0.1. The number of reads that map to introns or exons is a percentage of the total reads.